1st Circ. Upholds Block On Trump Admin NIH Funding Cuts

By Hailey Konnath

The First Circuit on Monday affirmed a Massachusetts federal judge's order permanently blocking the Trump administration from gutting National Institutes of Health funding for biomedical research, agreeing that the government didn't have the authority to cap indirect costs for research grants.

Opinion attached | Read full article » | Save to favorites »

Health Officials Roll Back Child Vaccine Recommendations

By Mark Payne

Amid public outcry, federal health officials on Monday revised vaccine recommendations for American children, cutting the number from 18 to 11 and bringing the United States in line with other developed countries such as Denmark. 

Read full article » | Save to favorites »

Ind. Sues Eli Lilly Over 'Grossly Inflated' Insulin Prices

By Gianna Ferrarin

Indiana's attorney general on Monday announced a state court suit against Eli Lilly alleging it schemed to artificially inflate the price of insulin, saying the litigation follows two years of ultimately unsuccessful attempts to resolve the matter without litigation against the drug manufacturer.

Complaint attached | Read full article » | Save to favorites »

Cancer Biotech Co. Eyes $182M IPO

By Grace Dixon

A company developing new drugs for treating cancer disclosed Monday it is looking to raise roughly $182 million in an initial public offering guided by Paul Hastings LLP and Davis Polk & Wardwell LLP, teeing it up for the first major IPO of 2026.

Read full article » | Save to favorites »

Trump Backs Biden's Medicare Drug Price Law At High Court

By Mark Payne

The Trump administration is defending the Biden-era Medicare Drug Price Negotiation program to the U.S. Supreme Court, asking the justices to deny AstraZeneca's petition challenging the program as unconstitutional.

Brief attached | Read full article » | Save to favorites »

3rd Circ. Won't Rethink Tax On Interest In $191M Pharma Deal

By Anna Scott Farrell

The Third Circuit declined to reconsider its decision that a pharmaceutical company's $191 million payment settling a family feud was for the sale of a family trust's ownership shares and included interest that should be taxed as ordinary income.

Order attached | Read full article » | Save to favorites »

Express Scripts Wants FTC Atty Views On Insulin Prices

By Matthew Perlman

Express Scripts is seeking to force an attorney from the Federal Trade Commission to sit for a deposition in the agency's case accusing pharmacy benefit managers of inflating insulin prices, saying the commission's own attorneys acknowledge that manufacturers cause higher prices.

Motion attached | Read full article » | Save to favorites »

Fed. Circ. Examines Timing Of $452M Trade Secrets Suit

By Ivan Moreno

A Federal Circuit panel delved into the statute of limitations for trade secrets cases Monday, pressing an attorney for a South Korean company seeking to reverse a verdict that prompted a $452 million jury award to explain why the clock should start when a plaintiff suspects misappropriation rather than when it is actually discovered.

Read full article » | Save to favorites »

Thesis Supplements Illegally Sold As ADHD Drugs, Suit Says

By Mike Curley

A Louisiana woman is suing the owner of Thesis Nootropics in New York federal court, alleging that the company's line of supplements is illegally marketed as an alternative to Adderall and other medications despite lacking federal approval.

Complaint attached | Read full article » | Save to favorites »

Brief

Aetna Drug Price-Fixing Suit Against Pharma Cos. Paused

By Aaron Keller

A judge has paused Aetna Inc.'s Connecticut Superior Court lawsuit accusing nearly two dozen pharmaceutical companies of fixing the prices of generic drugs, refusing drugmakers' bids to dismiss the case but agreeing to put it on hold pending the outcomes of similar cases in other jurisdictions.

Decision attached | Read full article » | Save to favorites »

Paul Hastings Adds Hogan Lovells Duo To Life Sciences Team

By Alison Knezevich

Two longtime Hogan Lovells partners, including the head of its pharmaceutical and biotechnology regulatory practice, have joined Paul Hastings LLP in Washington, D.C., the firm announced Monday.

Read full article » | Save to favorites »

A Meaningful Shift In FDA's Biosimilarity Analysis

The U.S. Food and Drug Administration's potential pivot away from routinely requiring comparative efficacy studies for interchangeable biosimilar applications would not lower regulatory standards, but instead allow applicants to allocate resources toward establishing more probative evidence, says Theodore Thompson at Stinson.

1 document attached | Read full article » | Save to favorites »

Trending At The PTAB: The Journey Of IPR Institution In 2025

Over the course of 2025, inter partes review institution at the Patent Trial and Appeal Board evolved into a more restrictive, policy-driven regime with reshaped discretionary briefing and assessment, and increasing procedural requirements, say attorneys at Finnegan.

Read full article » | Save to favorites »

Average Quinn Emanuel Partner Payouts Rise To $9.5M

By Aebra Coe

Quinn Emanuel Urquhart & Sullivan LLP saw a 10% uptick in its profits per equity partner in 2025, bringing the firm's average partner pay up over $9 million last year amid an active litigation market, a firm spokesperson confirmed Monday.

Read full article » | Save to favorites »

Feature

His Client Got A Pro Se Suit. Then The AI Filings Started.

By Chris Villani

Employment attorneys say the increased use of AI by pro se plaintiffs has the potential to clog dockets, drag out cases and make litigation significantly more expensive.

Read full article » | Save to favorites »

McGuireWoods Atty Fined Over Citation Errors In BoA Suit

By Chart Riggall

A Georgia federal judge has slapped a McGuireWoods LLP attorney with a $1,500 fine for using incorrect citations in a brief lodged in a recently dismissed mortgage suit against Bank of America.

Order attached | Read full article » | Save to favorites »

Quinn Emanuel Contempt In $600M Row Probed By Fed. Circ.

By Ryan Davis

A contempt finding against Quinn Emanuel Urquhart & Sullivan LLP that contributed to a more than $600 million patent judgment against the firm's former client NortonLifeLock was scrutinized by a Federal Circuit panel on Monday, with one judge saying the order appeared to be invalid.

Read full article » | Save to favorites »

Wis. Judge Resigns After Conviction In ICE Arrest Case

By Jack Karp

A Wisconsin state judge has resigned from the bench after being convicted of felony obstruction for helping an unauthorized immigrant in her court evade arrest by federal immigration officers, the Wisconsin Assembly speaker confirmed to Law360 Monday.

Read full article » | Save to favorites »

Federal Court Wrong Place For Judges' Suit, Justices Told

By Elaine Briseño

Federal immigration officials have asked the U.S. Supreme Court to reverse an appellate decision that allowed immigration judges to hash out their spat over a newly created speech policy in district court instead of within the congressionally designated special review system.

Petition attached | Read full article » | Save to favorites »

Roundup

The Top In-House Hires Of December

By Michele Gorman

Legal department hires during the last month of 2025 included high-profile appointments at Apple, Berkshire Hathaway and LPL Financial. Here, Law360 Pulse looks at some of the top in-house announcements from December.

Read full article » | Save to favorites »